MH3 COST-EFFECTIVENESS OF METHYLPHENIDATE OROS FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD)- AN EVALUATION FROM THE PERSPECTIVE OF THE UK NATIONAL HEALTH SERVICE (NHS)
May 1, 2004, 00:00
10.1016/S1098-3015(10)62116-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)62116-X/fulltext
Title :
MH3 COST-EFFECTIVENESS OF METHYLPHENIDATE OROS FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD)- AN EVALUATION FROM THE PERSPECTIVE OF THE UK NATIONAL HEALTH SERVICE (NHS)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62116-X&doi=10.1016/S1098-3015(10)62116-X
First page :
Section Title :
Open access? :
No
Section Order :
54